Radar Healthcare, a leading provider of risk, quality, and compliance software for the healthcare and social care sectors, today announced a majority growth investment from Marlin Equity Partners.

Sweetgreen shares can outperform with the help of disruptive technology. Patiently holding these stocks could pay off massively down the road. The bull market continued to drive the S&P 500 to new ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Taiwan Semiconductor is a smart play on AI infrastructure. These AI stocks will likely remain leaders for years to come. Nearly every technology company touts its artificial intelligence ...

The highlight of the week was the US$1 billion accord announced on the final day of the 2024 FII summit by the Saudi sovereign wealth fund and the HKMA.

The right online broker can help you execute your investment strategy and make trading cheap stocks seamless. Take a look at some of Benzinga’s favorites. You have found stocks to buy now cheap ...

No matter if you’re day trading penny stocks or you’re looking for stocks under $10 to add to your long-term portfolio, you need to open a brokerage account before you can begin trading.

This post was written by Angel Smith This year has been great for stocks, as indexes confirmed the presence of a bull market and then went on to reach multiple record highs. The Dow Jones ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Stocks and bonds are two of the most traded types of assets—each available for sale on several different platforms or through a variety of markets or brokers. And there are important ...

The stock has more than doubled in 2024 but is still trading under $5. Investors are growing increasingly optimistic that imetelstat could gain additional approvals. Geron is in phase 3 clinical ...